SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-24-000009
Filing Date
2024-02-09
Accepted
2024-02-09 17:08:13
Documents
18
Period of Report
2024-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20240208x8k.htm   iXBRL 8-K 87403
2 EX-10.1 alim-20240208xex10_1.htm EX-10.1 179625
3 EX-10.2 alim-20240208xex10_2.htm EX-10.2 69288
4 EX-10.3 alim-20240208xex10_3.htm EX-10.3 97453
5 EX-10.4 alim-20240208xex10_4.htm EX-10.4 69323
  Complete submission text file 0001267602-24-000009.txt   689392

Data Files

Seq Description Document Type Size
6 EX-101.SCH alim-20240208.xsd EX-101.SCH 2165
7 EX-101.LAB alim-20240208_lab.xml EX-101.LAB 18359
8 EX-101.PRE alim-20240208_pre.xml EX-101.PRE 11523
19 EXTRACTED XBRL INSTANCE DOCUMENT alim-20240208x8k_htm.xml XML 4765
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 24616050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)